Page 15 - HME Business, January/February 2020

meaning that the CBD has been isolated out of the hemp plant and in the product, and there are full-spectrum CBD products, which include all the other items that in the hemp plant.
There are 150 cannabinoids in the hemp plant, and that does not include the flavonoids and terpenes and other elements that are in the hemp. Those various elements work together
in what is called an “entourage effect” that compounds the efficacy of the CBD.
“Those chemical compounds interact with
one another, in some cases amplifying, in other cases inhibiting, in many cases still unknown how it all works,” Fedele says. “But I think that the consensus is that the full-spectrum hemp oil is the superior product in that they’ve found that it typi- cally requires less precise dosing.
“When you isolate the singular molecule of cannabidiol or CBD research has shown that, basically, the therapeutic window for proper dosing of that single-molecule CBD is much more difficult to achieve than when using a full-spectrum product,” he continues. “So, in other words, if you take too little of the single- molecule CBD or the CBD isolate, or if you take too much of the CBD isolate, you’re not going to get the same therapeutic benefit. It’s more
difficult to find that therapeutic window in the middle, whereas full-spectrum tends to work kind of better across all dosage.
This gives users some more flexibility in finding what works best for their needs.
“You could start at a lower dosage and simply titrate up or take a little bit more over the course of time as you are paying attention to the effects that it has on your body,” Fedele explains. “And when you achieve the desired effects, then you’ve kind of found your target dosage. Because cannabinoids affect humans or individuals each in a different way. So, what works for me might not exactly be what works for you.”
CBD is still a new category and that means it requires quite a bit of education. Fedele advises
that providers start working with a manufacturer or supplier that is also going to provide compre- hensive training and support. A good vendor can get a provider ramped up on product knowledge so that they can more expertly serve their local community.
“Everything revolves around the training,” he says. “So we have both a kind of a beginners level course, almost like a CliffsNotes version of CBD. Everything from what is CBD up through laws and regulations, the history of cannabis, the endo- cannabinoid system. And then we also have a 120-page comprehensive training academy that’s more of the advanced guide.”
In addition to those, PurWell offers its providers training videos and one-on-one sessions.
The CBD opportunity is massive. According to market researcher firm the Brightfield Group, the global CBD market could expand to $22 billion by 2022. Another study from Cowen and Company projects the U.S. CBD market to hit roughly $16 billion by 2025. Those kinds of numbers are hard to ignore.
OUR INNOVATIVE PROGRAMS HAVE GAINED INDUSTRY RECOGNITION THREE YEARSINAROW.
Contact us.
By HME Business
New Product Award in Business Services
In recognition of The Compliance Team’s development of new and unique programs that enhance the market.
Programs recognized:
2017 Patient-Centered Pharmacy HomeTM 2018 Patient-Centered Respiratory HomeTM 2019 Diabetes Self Management Training
With award-winning programs that help patients and providers, The Compliance Team is the best choice for DMEPOS accreditation.
Website: TheComplianceTeam.org Email: info@TheComplianceTeam.org Call: (215) 654-9110
*The Compliance Team, Inc. is approved by the Centers for Medicare and Medicaid Services to accredit Part A-Rural Health Clinic, Patient-Centered Medical Home, and Part B-DMEPOS providers.
Management Solutions | Technology | Products hme-business.com | January/February 2020 | HMEBusiness 15 Untitled-9 1 1/6/20 1:21 PM